The Controversy Over Unvaccinated Blood Transfusions
A growing number of patients are expressing a preference for blood donations from unvaccinated individuals, raising ethical and medical questions.
A growing number of patients are expressing a preference for blood donations from unvaccinated individuals, raising ethical and medical questions.
Eli Lilly has announced encouraging results from a recent clinical trial of its gene-editing therapy, indicating a significant reduction in cholesterol levels among participants.
The lack of diverse voices in professional and educational environments often goes unnoticed, impacting decision-making and fostering a homogeneous culture.
The question of how much enriched uranium Iran possesses remains uncertain, raising concerns about its nuclear capabilities and regional implications.
Recent research suggests that graphene quantum dots may play a significant role in targeting toxic protein aggregates associated with neurodegenerative diseases like Parkinson's.
Researchers at Osaka Metropolitan University have introduced a novel light-driven method that efficiently concentrates bacteria, potentially improving diagnostic capabilities.
This summer, at least 16 individuals have succumbed to heatstroke in southern India as temperatures continue to rise, prompting health warnings from officials.
A recent doctoral thesis from the University of Gothenburg suggests that fluctuations in work capacity may serve as early indicators of potential sick leave, paving the way for better employee support.
Green chemistry presents a transformative approach to resource usage, aiming to minimize waste and harmful substances while balancing benefits with environmental health.
With Congress reducing Medicaid funding for healthcare providers, the Trump administration is pushing for further cuts, leaving hospitals to prepare for the financial ramifications on patient care.
As natural disasters become more frequent, the pressure on disaster responders intensifies, potentially compromising their health and effectiveness due to unclear tasks and command structures.
Recent discussions reveal a split between EU and US advisers regarding AstraZeneca's breast cancer drug, amid notable developments in other biotech areas.
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.
A recent CDC page on mpox has become a focal point of political debate, highlighting issues related to public health communication amid rising concerns about various health topics.
As the establishment of a federal office dedicated to men's health appears imminent, concerns grow over its potential fate under future administrations.
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Recent findings reveal significant issues with the release of drugs from nanoparticle carriers, raising concerns for the future of precision medicine.
Scientists at Northwestern Medicine have introduced a novel method to study protein domain fluctuations, potentially advancing data-driven modeling in biology.
A targeted chemotherapy developed by Kelun-Biotech and licensed to Merck shows a 65% reduction in tumor progression risk for lung cancer patients in Phase 3 trials.
Shares in US cosmetics giant jump 11.5% in post-market trading as investors welcome end of talks